Three rSNPs (rs3125289, rs1877474 and rs11119982) in one intron of the activating transcription factor 3 (ATF3) gene have been significantly associated with the human etiology of hypospadias and may be associated with human disease. These rSNP alleles alter the DNA landscape for potential transcriptional factors (TFs) to attach resulting in changes in transcriptional factor binding sites (TFBS). These TFBS changes are examined with respect to the human etiology of hypospadias which has been found to be significantly associated with the rSNPs.
INTRODUCTION
The activating transcription factor 3 (ATF3) gene is a member of the activating transcription factor/cAMP responsive element binding (CREB) protein family of transcription factors, which share the basic region-leucine zipper (bZip) DNA binding motif (TGACGTCA). This gene is induced by a variety of signals including many of those encountered by cancer cells, and is involved in the complex process of cellular stress response [1] [2] [3] . ATF3 has been viewed as a hub of the cellular adaptive response network which allows cells adapt to disturbances in homeostasis [4] . This gene has been shown to be up-regulated during sexual differentiation [5] which indicates a potential role in hypospadias. Three unlinked ATF3 SNPs (rs3125289, rs1877474 and rs11119982) which span a 16 kb region of intron one have been independently found to be significantly associated with the risk of hypospadias [6] . This suggests that these SNPs in intron one may be part of a regulatory region for the ATF3 gene. To follow up on this possibility, the SNPs were examined for associations to potential transcription factor binding sites (TFBS).
Single nucleotide changes that affect gene expression by impacting gene regulatory sequences such as promoters, enhancers, and silencers are known as regulatory SNPs (rSNPs) [7] [8] [9] [10] . A rSNPs within a transcriptional factor binding site (TFBS) can change a transcriptional factor's (TF) ability to bind its TFBS [11] [12] [13] [14] , in which case the TF would be unable to effectively regulate its target gene [15] [16] [17] [18] [19] . This concept is examined for the above ATF3 SNPs of intron one and their allelic association with TFBS. In this report, I discuss these SNP associations with changes in potential TFBS and their possible relationship to human etiology.
MATERIALS AND METHODS

Identifying TFBS
The JASPAR CORE database [20, 21] and ConSite [22] were used to identify the TFBS in this study. JASPAR is a collection of transcription factor DNA-binding preferencesused for scanning genomic sequences where ConSite is a web-based tool for finding cis-regulatory elements in genomic sequences. The Vector NTI Advance 11 computer program (Invitrogen, Life Technologies) was used to locate the TFBS in the ATF3 gene (NCBI Ref Seq NM_001674) from 51 kb upstream of the transcriptional start site to 766 bp past the 3'UTR which represents a total of 57.6 Kbp. The JASPAR CORE database was also used to compute each nucleotide occurrence (%) within the TFBS where upper case lettering indicate that the nucleotide occurs 90% or greater and lower case less than 90%. The occurrence of each SNP allele in the TFBS is also computed from the database ( This gene is one of seven ATFs that influence cellular physiologic processes by regulating the expression of downstream target genes, which are related to growth, survival, and other cellular activities. The three ATF3 rSNPs [rs3125289 (C/T), rs1877474 (C/T) and rs-11119982 (C/T)] in intron one has been found to be significantly associated with the risk of hypospadias [6] . The rs3125289 and rs1877474 AFT3-T alleles have a significantly greater occurrence in the case subjects compared to the corresponding control group where the rs11119982 ATF3-C allele has a significantly greater advantage [6] . The rs3125289 ATF3-C allele creates eight unique TFBS for the ARNT, ARNT:AHR, GABPA, MYC, MYCN, MZF1_1-4, SPIB and USF1 TFs which are involved in xenobiotic metabolism, cell cycle progression, apoptosis, cellular transformation, a variety of tumors, lymphoid-specific enhancer and cellular transcription, respectively ( Table 1) . The rs3125289 ATF3-T allele also creates eight unique TFBS for the FOXA1 & 2, FOXL1, FOXO3, HLTF, SOX10 & 17 and SRY TFs which are involved in embryonic development, apoptosis, chromatin structure, cell fate and male development, respectively (Table 1 & Supplement). Three TFBS have been conserved between the two rs3125289 alleles which are for the ELF4, FOXC1 and TBP TFs that regulate epithelium-specific genes, resistance to oxidative stress and a core factor in DNA binding for TFIID, respectively ( Table 1) .
The rs1877474 AFT3-C allele creates no unique TFBS while the AFT3-T allele creates three unique TFBS which are for the ETS1, FOXA1 and SOX10 TFs which interact with TTRAP, UBE2I and Death associated proteins and regulates embryonic development, respectively ( Table 1) . Two TFBS have been conserved between the two alleles which are HLTF and SPIB TFs that are involved in altering chromatin structure and act as a lymphoid-specific enhancer, respectively ( Table 1) .
The rs11119982 ATF3-C allele creates one unique TFBS for the HLTF TF which is involved with altering chromatin structure. The ATF3-T allele creates five unique TFBS for the ARID3A, MAX, MYB, USF1 and ZEB1 TFs. These TFs are involved with the AT-rich interaction domain, transcription regulation, hematopoietic progenitor cells control, cellular transcription and repression, respectively ( Table 1) . Eight TFBS have been conserved between the two alleles which are ARNT, ARNT: AHR, GATA2 & 3, HKX2 & 3, PAX2 and TFAP2A TFs that are involved with xenobiotic metabolism, hematopoietic and endocrine cell lineages, endothelial cell boilogy, transcription repression, kidney cell differentiation and transcription activation, respectively ( Table 1 ).
DISCUSSION
GWAS over the last decade have identified nearly 6500 disease or trait-predisposing SNPs where only 7% of these are located in protein-coding regions of the genome [23, 24] and the remaining 93% are located within noncoding areas [25, 26] such as regulatory or intergenic regions. SNPs which occur in the putative regulatory region of a gene where a single base change in the DNA sequence of a potential TFBS may affect the process of gene expression, which are drawing more attention [7, 9, 27] . A SNP in a TFBS can have multiple consequences. Often the SNP does not change the TFBS interaction nor does it alter gene expression since a transcriptional factor (TF) will usually recognize a number of different binding sites in the gene. In some cases, the SNP may increase or decrease the TF binding which results in allele-specific gene expression. In rare cases, a SNP may eliminate the natural binding site or generate a new binding site. In the cases, the gene is no longer regulated by the original TF. Therefore, functional rSNPs in TFBS may result in differences in gene expression, phenotypes and susceptibility to environmental exposure [27] . Examples of rSNPs associated with disease susceptibility are numerous and several reviews have been published [27] [28] [29] [30] .
In this report, the rs3125289 ATF3-C allele [C (+ strand) or G (−strand)] located in the ARNT and ARNT: AHR TFBS has a 100% and 96% occurrence, respectively, in humans; however, these BS occurs seven times in the gene and therefore a change in the TFBS created by the rSNP would probably not have any impact on the regulation of the gene (Table 1 & Supplement) . The ATF3-C allele is also located in the MYC and MYCN TFBS with a 90% occurrence and this BS occurs only once in the gene and therefore a nucleotide change created by the rSNP on these TFBS would probably have an impact on the regulation of the gene. The rs3125289 ATF3-T allele located in the FOXA2 and SRY TFBS has a 100% occurrence in humans and each BS occurs only once in the gene; therefore, the rSNP would probably have an impact on the regulation of the gene. Since the SRY TF located on the Y chromosome is a transcriptional regulator that controls a genetic switch in male development, this rSNP might be expected to have an impact on male etiology as has been shown to be the case with its risk of hypospadias [6] .
The rs1877474 ATF3-T allele [A (−strand) or T (+ strand)] located in the FOXA1 TFBS has an occurrence of 91% in humans and this BS occurs only once in the gene and thereby might have an impact on embryonic development and tissue differentiation ( Table 1) . The other two unique TFBS (ETS1 and SOX10) occur multiple times in the gene and would not be expected to have an impact on gene regulation. The rs1877474 ATF3-C allele does not have any unique TFBS and therefore would not be expected to have any impact on gene regulation.
The rs11119982 ATF3-C allele [C (+strand) or G (− strand)] located in the HLTF TFBS has an occurrence of 37% in humans (table). While this BS motif occurs only once in the gene and other HLTF BS motifs are found in intron one, it is doubtful that a change in the BS created by the rSNP would have an impaction on gene regulation. The rs11119982 ATF3-T allele located in the MYB TFBS has a 100% nucleotide occurrence for that BS motif in humans and occurs only once in the gene and thereby may have an impact on gene regulation and in the control of proliferation and differentiation of hematopoietic progenitor cells. Other rs11119982 ATF3-T allele unique TFBS affected by this rSNP occur multiple times in the gene and would probably have little effect on gene regulation. Since each of these rSNPs can alter TFBS in ATF3 intron one, it is easy to understand why the rSNPs have been found to independently affect the risk of hypospadias [6] .
Human diseases or conditions that have been significantly associated with these rSNPs of the ATF3 gene are shown in the table along with rSNP allele-specific TFBS. What a change in the rSNP alleles can do, is to alter the DNA landscape around the SNP for potential TFs to attach and regulate a gene. This change in the regulatory landscape can alter gene regulation which in turn can result in human disease, a change in condition or illness. In this report, three intron one rSNPs of the ATF3 gene have been described to illustrate that a change in rSNP alleles can provide different TFBS which in turn are also significantly associated with human etiology.
Supplement. TF discription.
TFs
TF discription
ARID3A
This gene encodes a member of the ARID (AT-rich interaction domain) family of DNA binding proteins.
ARNT
Involved in the induction of several enzymes that participate in xenobiotic metabolism.
ARNT:AHR The dimer alters transcription of target genes. Involved in the induction of several enzymes that participate in xenobiotic metabolism.
ELF5
The protein encoded by this gene is a member of an epithelium-specific subclass of the Etstranscritpion factor family. In addition to its role in regulating the later stages of terminal differentiation of keratinocytes, it appears to regulate a number of epithelium-specific genes found in tissues containing glandular epithelium such as salivary gland and prostate.
ETS1
The protein encoded by this gene belongs to the ETS family of transcription factors and has been shown to interact with TTRAP, UBE2I and Death associated proteins.
FOXA1
Transcription factor that is involved in embryonic development, establishment of tissue-specific gene expression and regulation of gene expression in differentiated tissues.
FOXA2
FOXC1
This gene belongs to the forkhead family of transcription factors which is characterized by a distinct DNA-binding forkhead domain. An important regulator of cell viability and resistance to oxidative stress.
FOXL1
This gene encodes a member of the forkhead/winged helix-box (FOX) family of transcription factors.
FOXO3
This gene belongs to the forkhead family of transcription factors which are characterized by a distinct forkhead domain. This gene likely functions as a trigger for apoptosis through expression of genes necessary for cell death.
GABPA
This gene encodes one of three GA-binding protein transcription factor subunits which functions as a DNA-binding subunit.
GATA2
A member of the GATA family of zinc-finger transcription factors that are named for the consensus nucleotide sequence they bind in the promoter regions of target genes and play an essential role in regulating transcription of genes involved in the development and proliferation of hematopoietic and endocrine cell lineages.
GATA3
Plays an important role in endothelial cell biology.
HLTF
This gene encodes a member of the SWI/SNF family. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes.
MAX
The protein encoded by this gene is a member of the basic helix-loop-helix leucine zipper (bHLHZ) family of transcription factors. Transcription regulator.
MYB
This gene encodes a transcription factor that is a member of the MYB family of transcription factor genes. Transcriptional activator and plays an important role in the control of proliferation and differentiation of hematopoietic progenitor cells.
MYC
The protein encoded by this gene is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation.
MYCN
This gene is a member of the MYC family and encodes a protein with a basic helix-loop-helix (bHLH) domain. Amplification of this gene is associated with a variety of tumors, most notably neuroblastomas.
MZF1_1-4 Trancription regulator
NKX2-5
This gene encodes a member of the NK family of homeobox-containing proteins. Transcriptional repressor that acts as a negative regulator of chondrocyte maturation.
NKX3-2
PAX2
Probable transcription factor that may have a role in kidney cell differentiation.
SOX10
This gene encodes a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation of embryonic development and in the determination of the cell fate.
SOX17
Acts as transcription regulator that binds target promoter DNA and bends the DNA.
SPIB
The protein encoded by this gene is a transcriptional activator that binds to the PU-box (5'-GAGGAA-3') and acts as a lymphoid-specific enhancer.
